Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025)

Organogenesis Holdings' (ORGO) quarterly Construction in Progress came in at $26.7 million in Q4 2025, up 22.19% year-on-year from $21.9 million in Q4 2024, and down 2.9% quarter-over-quarter from $27.5 million in Q3 2025.

Organogenesis Holdings (ORGO) Construction in Progress (2023 - 2025) Analysis & Trends

Organogenesis Holdings' Construction in Progress history runs 3 years deep, the most recent figure standing at $26.7 million for Q4 2025.

  • On a quarterly basis, Construction in Progress rose 22.19% year-over-year to $26.7 million in Q4 2025; TTM through Dec 2025 was $26.7 million, a 22.19% increase from a year earlier, with the FY2025 full-year figure at $26.7 million, up 22.19% from the prior year.
  • Construction in Progress fell to $26.7 million in Q4 2025 per ORGO's latest filing, from $27.5 million in the prior quarter.
  • Across five years, Construction in Progress topped out at $59.1 million in Q4 2023 and bottomed at $20.6 million in Q3 2024.
  • The 3-year median for Construction in Progress is $23.9 million (2025), against an average of $29.1 million.
  • Across the five-year window, Construction in Progress tumbled 62.95% in 2024 and soared 33.66% in 2025, its largest moves.
  • Year by year, Construction in Progress stood at $59.1 million in 2023, then tumbled by 62.95% to $21.9 million in 2024, then advanced by 22.19% to $26.7 million in 2025.
  • Per Business Quant, the three latest ORGO Construction in Progress figures stand at $26.7 million (Q4 2025), $27.5 million (Q3 2025), and $23.9 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Organogenesis Holdings 310.55 Mn 218.45 Mn 11.46 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 26.74 Mn
Sep 30, 2025 27.54 Mn
Jun 30, 2025 23.94 Mn
Mar 31, 2025 23.76 Mn
Dec 31, 2024 21.89 Mn
Sep 30, 2024 20.61 Mn
Dec 31, 2023 59.07 Mn